探索ID4作为攻击的驱动力和三阴性乳腺癌的治疗点
C Toro1, S Real2,3, S Laurito1,2
1Facultad de Ciencias Exactas y Naturales. Universidad Nacional de Cuyo, Mendoza, Argentina.
NPJ breast cancer
|July 10, 2025
概括
抑制ID4蛋白,经常发现在侵略性的基底类乳腺癌 (BLBC),显著减少瘤生长和改善患者的生存率. 这表明ID4抑制是三阴性乳腺癌的有希望的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 基底类乳腺癌 (BLBC) 是一种具有有限治疗选择的侵袭性亚型.
- 抑制差异化4 (ID4) 蛋白在BLBC进展中的作用尚不清楚.
- 在BLBC中,ID4经常过度表达,与预后不佳相关.
研究的目的:
- 调查ID4在基底类乳腺癌中的功能性作用.
- 确定ID4抑制是否可以作为三阴性乳腺癌 (TNBC) 的治疗策略.
主要方法:
- 在癌症细胞系中,CRISPR-Cas9介导的ID4淘汰.
- 使用AGX51.1,药理上抑制ID4.
- 在体内异种移植研究以评估瘤生长.
- 转录和转录因子活动分析.
- 对癌症基因组图谱 (TCGA) 数据的分析.
主要成果:
- 失去ID4显著降低了MDA-MB-231细胞增殖,殖民地形成和体内瘤生长.
- 患者的低ID4表达与改善的无复发存活率相关.
- 低ID4的瘤表现出类似光线的转录形状,具有增加的雌激素反应和炎症信号.
- 用AGX51抑制TNBC细胞增殖的ID4抑制.
结论:
- ID4是基底性乳腺癌攻击性的关键驱动因素.
- 准ID4是一种有前途的治疗策略,可以改善三阴性乳腺癌的治疗结果.
- 抑制ID4可能会促进转向更差异化的瘤表型.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.8K
08:37Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
10.0K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665
02:38Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K